iCAD Awarded New CAD Patent For Integrating Information From Multiple Mammography Images

iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that the United States Patent and Trademark Office recently granted the Company U.S. Patent No. 7,333,645. This patent addresses how the Company’s CAD systems can improve cancer detection by applying technology that integrates information from multiple mammography images, including prior exams.

“We are continuously working to enhance our CAD offerings, including the development of technologies that will further improve CAD performance for radiologists,” said Ken Ferry, President and Chief Executive Officer of iCAD. “It is a strategic priority to expand our portfolio of patents that protect our intellectual property and the innovation that powers iCAD products in the detection of cancer, and we are delighted to be granted this new patent.”

source: iCAD